ACCENTMICPharmaceuticals
ACCENTMICST — Profit & Loss Statement
₹267.00
+0.00%
ACCENTMICST Profit & Loss Statement (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | -0.41 Cr | 70416.53 | -6704.26 | -0.07 Cr |
| Tax Rate For Calcs | 0.17 | 0.17 | 0.22 | 0.20 |
| Normalized EBITDA | 44.32 Cr | 21.01 Cr | 14.51 Cr | 12.83 Cr |
| Total Unusual Items | -2.37 Cr | 0.04 Cr | -30000.00 | -0.37 Cr |
| Total Unusual Items Excluding Goodwill | -2.37 Cr | 0.04 Cr | -30000.00 | -0.37 Cr |
| Net Income From Continuing Operation Net Minority Interest | 30.17 Cr | 12.23 Cr | 5.89 Cr | 4.80 Cr |
| Reconciled Depreciation | 4.43 Cr | 4.11 Cr | 4.15 Cr | 3.55 Cr |
| Reconciled Cost Of Revenue | 171.12 Cr | 144.83 Cr | 119.15 Cr | 96.63 Cr |
| EBITDA | 41.95 Cr | 21.05 Cr | 14.51 Cr | 12.47 Cr |
| EBIT | 37.52 Cr | 16.94 Cr | 10.36 Cr | 8.91 Cr |
| Net Interest Income | -0.03 Cr | -2.47 Cr | -3.00 Cr | -3.30 Cr |
| Interest Expense | 1.00 Cr | 2.14 Cr | 2.77 Cr | 2.91 Cr |
| Interest Income | 1.11 Cr | 0.06 Cr | 0.06 Cr | 0.08 Cr |
| Normalized Income | 32.12 Cr | 12.20 Cr | 5.90 Cr | 5.10 Cr |
| Net Income From Continuing And Discontinued Operation | 30.17 Cr | 12.23 Cr | 5.89 Cr | 4.80 Cr |
| Total Expenses | 208.12 Cr | 182.36 Cr | 156.52 Cr | 123.72 Cr |
| Rent Expense Supplemental | 0.45 Cr | 0.32 Cr | 0.23 Cr | 0.18 Cr |
| Diluted NI Availto Com Stockholders | 30.17 Cr | 12.23 Cr | 5.89 Cr | 4.80 Cr |
| Net Income Common Stockholders | 30.17 Cr | 12.23 Cr | 5.89 Cr | 4.80 Cr |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 30.17 Cr | 12.23 Cr | 5.89 Cr | 4.80 Cr |
| Net Income Including Noncontrolling Interests | 30.17 Cr | 12.23 Cr | 5.89 Cr | 4.80 Cr |
| Net Income Discontinuous Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Continuous Operations | 30.17 Cr | 12.23 Cr | 5.89 Cr | 4.80 Cr |
| Tax Provision | 6.36 Cr | 2.57 Cr | 1.70 Cr | 1.20 Cr |
| Pretax Income | 36.53 Cr | 14.80 Cr | 7.59 Cr | 6.00 Cr |
| Other Non Operating Income Expenses | 0.03 Cr | 0.06 Cr | 0.04 Cr | 26000.00 |
| Special Income Charges | -2.37 Cr | 0.04 Cr | -30000.00 | -0.37 Cr |
| Other Special Charges | 1.10 Cr | -0.04 Cr | 30000.00 | 0.29 Cr |
| Write Off | 1.27 Cr | 0.00 | 0.00 | 0.08 Cr |
| Net Non Operating Interest Income Expense | -0.03 Cr | -2.47 Cr | -3.00 Cr | -3.30 Cr |
| Total Other Finance Cost | 0.15 Cr | 0.39 Cr | 0.29 Cr | 0.47 Cr |
| Interest Expense Non Operating | 1.00 Cr | 2.14 Cr | 2.77 Cr | 2.91 Cr |
| Interest Income Non Operating | 1.11 Cr | 0.06 Cr | 0.06 Cr | 0.08 Cr |
| Operating Income | 37.38 Cr | 14.92 Cr | 9.19 Cr | 8.85 Cr |
| Operating Expense | 37.00 Cr | 37.52 Cr | 37.37 Cr | 27.09 Cr |
| Other Operating Expenses | 6.63 Cr | 6.49 Cr | 5.65 Cr | 5.12 Cr |
| Depreciation And Amortization In Income Statement | 4.43 Cr | 4.11 Cr | 4.15 Cr | 3.55 Cr |
| Amortization | 0.01 Cr | 0.01 Cr | 0.12 Cr | 0.12 Cr |
| Depreciation Income Statement | 4.42 Cr | 4.10 Cr | 4.03 Cr | 3.43 Cr |
| Selling General And Administration | 8.18 Cr | 12.39 Cr | 14.73 Cr | 7.82 Cr |
| Selling And Marketing Expense | 6.93 Cr | 11.16 Cr | 13.81 Cr | 7.10 Cr |
| General And Administrative Expense | 1.26 Cr | 1.22 Cr | 0.92 Cr | 0.72 Cr |
| Rent And Landing Fees | 0.45 Cr | 0.32 Cr | 0.23 Cr | 0.18 Cr |
| Gross Profit | 74.38 Cr | 52.44 Cr | 46.56 Cr | 35.93 Cr |
| Cost Of Revenue | 171.12 Cr | 144.83 Cr | 119.15 Cr | 96.63 Cr |
| Total Revenue | 245.50 Cr | 197.27 Cr | 165.71 Cr | 132.57 Cr |
| Operating Revenue | 245.50 Cr | 197.27 Cr | 165.71 Cr | 132.57 Cr |
| Diluted Average Shares | — | 2.10 Cr | 2.10 Cr | 2.10 Cr |
| Basic Average Shares | — | 2.10 Cr | 2.10 Cr | 2.10 Cr |
| Diluted EPS | — | 5.81 | 2.80 | 2.28 |
| Basic EPS | — | 5.81 | 2.80 | 2.28 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on ACCENTMICST
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.